Advanced Accelerator (AAAP) Cancer Therapy Approved in EU | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.
MENU

Advanced Accelerator (AAAP) Cancer Therapy Approved in EU

Advanced Accelerator (AAAP) Cancer Therapy Approved in EU
Peptide News from Biotech and Pharma, Raw News October 2, 2017

Lutathera, a peptide receptor radionuclide therapy, is the company's first drug approved as a therapeutic drug for GEP-NET. However, Advanced ...

Email

support@boulderpeptide.org

s2Member®
loading...